ArticleBMJ open2022

Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial).

Pavel Osmancik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.